Calendar | For Your Patients | PHA Main Site | Contact Us | About Us | Not a registered user? Sign up here.

Resource Library

Managing Multiple Oral Therapies

Christine Archer-Chicko

Faith Pa'ahana-Janowick


  Sign in to add a review

Leave a Comment

Conference: 2007 PH Resource Network Symposium

Release Date: 10.12.2007

Presentation Type: Breakout Sessions

File Download: 2007 Symposium Oral therapies

Download Adobe Acrobat

Prior to 2001 there were no FDA approved oral therapies for PAH except calcium channel blockers. Bosentan was the first orally approved PAH specific medication. Since then the FDA has approved sildenafil and ambrisentan. these newer oral agents work by targeting different pathways. These medications will be reviewed along with the advantages, disadvantages, dosing and cost of each.